Bristol-Myers Squibb (BMY) Tops Q2 EPS by 43c, Beats on Revenue; Offers FY26 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $59.12 -0.77%
EPS Growth %: +6.1%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
HOVR, VFS, PGR, More
EPS Growth %: +6.1%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $2.04, $0.43 better than the analyst estimate of $1.61. Revenue for the quarter came in at $12.97 billion versus the consensus estimate of $11.71 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2026 EPS of $6.75-$7.00, versus the consensus of $6.34. Bristol-Myers Squibb sees FY2026 revenue of $49.5-50 billion, versus the consensus of $47.5 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- Trump to issue directive to U.S. officials that seeks to control cost of diesel - Reuters
- Quantum Corporation CFO terminated, replaced by chief accounting officer
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
